OurCrowd portfolio company ReWalk was featured in Wired, a popular news site and magazine covering technology, culture, business and politics. FDA approved ReWalk has developed an exoskeleton device that enables paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits.

While visiting his doctor at the VA one day in November, [Gene Laureano] was wheeling himself past the Spinal Cord Damage Research Center, when he saw a contraption he describes as “a robot with sneakers.” It was the ReWalk, a kind of computerized exoskeleton. In January 2013, Laureano joined a clinical trial of the device at the VA, and more than a decade after he was told he would never walk again, he took his first steps.

The day I stood up, I knew I was about to cross the threshold from impossible to possible,” he says. “It was a moment for me.”

 

ReWalk raised $1,320,000 from OurCrowd investors in June 2013.

Read more on Wired here.